Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Washington University
1716
mi
from 98109
St Louis, MO
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Washington University
1716
mi
from 98109
St Louis, MO
Click here to add this to my saved trials
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Center for Movement Disorders and Neurorestoration
2452
mi
from 98109
Gainesville, FL
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Center for Movement Disorders and Neurorestoration
2452
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Dauer Hall, University of Florida
2453
mi
from 98109
Gainesville, FL
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Dauer Hall, University of Florida
2453
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
University of Miami
2730
mi
from 98109
Miami, FL
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
University of Miami
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
University of South Florida
2523
mi
from 98109
Tampa, FL
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
University of South Florida
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Emory University
2178
mi
from 98109
Atlanta, GA
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2400
mi
from 98109
New York, NY
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
1890
mi
from 98109
Houston, TX
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
5041
mi
from 98109
Marburg,
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
5041
mi
from 98109
Marburg,
Click here to add this to my saved trials
Genetic Analysis of Parkinson's Disease
Genetic Analysis of Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Genetic Analysis of Parkinson's Disease
Genetic Analysis of Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Gene Analysis of Parkinson's Disease
Gene Analysis in Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Gene Analysis of Parkinson's Disease
Gene Analysis in Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Cell Studies of Parkinson's Disease
Bioenergetic Function in Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Cell Studies of Parkinson's Disease
Bioenergetic Function in Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Sequence Effect in Parkinson's Disease
The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Sequence Effect in Parkinson's Disease
The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Southern California
962
mi
from 98109
Los Angeles, CA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Southern California
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
The Parkinson's Institute
706
mi
from 98109
Sunnyvale, CA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
The Parkinson's Institute
706
mi
from 98109
Sunnyvale, CA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Pacific Health Research & Education Institute
2678
mi
from 98109
Honolulu, HI
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Pacific Health Research & Education Institute
2678
mi
from 98109
Honolulu, HI
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Struthers Parkinson`S Center
1386
mi
from 98109
Golden Valley, MN
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Struthers Parkinson`S Center
1386
mi
from 98109
Golden Valley, MN
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Feinstein Institute For Medical Research, North Shore-Lij Health System
2413
mi
from 98109
Manhasset, NY
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Feinstein Institute For Medical Research, North Shore-Lij Health System
2413
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Pennsylvania Hospital
2373
mi
from 98109
Philadelphia, PA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Pennsylvania Hospital
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Vermont
2326
mi
from 98109
Burlington, VT
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Vermont
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Universitatsklinikum Giessen U. Marburg GmbH
5042
mi
from 98109
Standort Marburg,
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Universitatsklinikum Giessen U. Marburg GmbH
5042
mi
from 98109
Standort Marburg,
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
2725
mi
from 98109
Aventura, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
2707
mi
from 98109
Baco Raton, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
2707
mi
from 98109
Baco Raton, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
2730
mi
from 98109
South Miami, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
2730
mi
from 98109
South Miami, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
1917
mi
from 98109
Bingham Farms, MI
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
1917
mi
from 98109
Bingham Farms, MI
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
2358
mi
from 98109
Raleigh, NC
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
2358
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
University of Chicago
1737
mi
from 98109
Chicago, IL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
University of Chicago
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Cornell Univ Med Ctr
2402
mi
from 98109
New York, NY
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Cornell Univ Med Ctr
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/2/2015
California Clinical Trials
955
mi
from 98109
Glendale, CA
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/2/2015
California Clinical Trials
955
mi
from 98109
Glendale, CA
Click here to add this to my saved trials
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/2/2015
PARAXEL International
mi
from 98109
Baltimore, MD
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/2/2015
PARAXEL International
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Electromyography Signals as Biomarkers for Parkinson's Disease
Electromyography Signals as Biomarkers for Parkinson's Disease
Status: Enrolling
Updated:  10/7/2015
Norconnect Inc.
2216
mi
from 98109
Ogdensburg, NY
Electromyography Signals as Biomarkers for Parkinson's Disease
Electromyography Signals as Biomarkers for Parkinson's Disease
Status: Enrolling
Updated: 10/7/2015
Norconnect Inc.
2216
mi
from 98109
Ogdensburg, NY
Click here to add this to my saved trials
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Status: Enrolling
Updated:  10/8/2015
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
1112
mi
from 98109
Phoenix, AZ
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Status: Enrolling
Updated: 10/8/2015
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Balance Disorders Clinic
2330
mi
from 98109
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Balance Disorders Clinic
2330
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Fitness and Wellness Center
2329
mi
from 98109
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Fitness and Wellness Center
2329
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials